Full Text View
Tabular View
No Study Results Posted
Related Studies
Chinese Cohort Study of Coronary Heart Disease (CCS-CHD)
This study is currently recruiting participants.
Verified by Ministry of Science and Technology of the People´s Republic of China, May 2008
First Received: September 2, 2008   No Changes Posted
Sponsored by: Ministry of Science and Technology of the People´s Republic of China
Information provided by: Ministry of Science and Technology of the People´s Republic of China
ClinicalTrials.gov Identifier: NCT00745628
  Purpose

Construction of coronary heart disease cohort of more than 10000 patients in China. Investigation on current situation of secondary prevention of CHD will be carried out and the effect of physician training and patient education will be evaluated.


Condition
Coronary Heart Diseases

Study Type: Observational
Study Design: Cohort, Prospective
Official Title: Cross-Sectional Investigation of Secondary Prevention on Coronary Heart Disease and Generalization of Standardized Secondary Prevention in Chinese Coronary Heart Disease Patients

Resource links provided by NLM:


Further study details as provided by Ministry of Science and Technology of the People´s Republic of China:

Biospecimen Retention:   None Retained

Biospecimen Description:

Estimated Enrollment: 10000
Study Start Date: May 2008
Estimated Study Completion Date: December 2010
Estimated Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
Detailed Description:

More than 40 hospitals of 16 provinces will enroll patients for this study. The study will include patients with diagnosed coronary heart disease. Investigators and all the physicians who will involve in daily care of CHD patients will have a brief training on guideline of secondary prevention in CHD and take a test on that.

Questionnaires are used to evaluate patient's cognition of their diseases and knowledge on coronary heart disease. Patient education will be carried out during a 2 years follow up of all the patient enrolled before they are required to fill out another questionnaire. Physicians will also take a second test on secondary prevention of CHD at that time. Patients will take blood lipids and glucose test according to their physician's requirement.The effect of physician training and patient education will be evaluated by comparing the results of questionnaires and tests at the beginning of the study and in the end of the 2 years follow up.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Diagnosed coronary heart disease

Criteria

Inclusion Criteria:

  • Diagnosed coronary heart disease
  • Confirmed by coronary angiography;
  • Diagnosed myocardial infarction;
  • Typical symptom of ischemic chest pain with positive stress test;
  • Willing to sign an inform consent.

Exclusion Criteria

  • Patients won't sign an inform consent or will not comply with the follow up.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00745628

Contacts
Contact: Tao Hong, MD 86-10-66551122 ext 2229 dr_hongtao@163.com

Locations
China
Peking University First Hospital Recruiting
Beijing, China, 100034
Contact: Tao Hong     86-10-66551122 ext 2229     dr_hongtao@163.com    
Sponsors and Collaborators
Ministry of Science and Technology of the People´s Republic of China
Investigators
Principal Investigator: Tao Hong, MD Peking University First Hospital
  More Information

No publications provided

Responsible Party: Peking University First Hospital ( YHuo,director )
Study ID Numbers: 2006BAI01A02-08
Study First Received: September 2, 2008
Last Updated: September 2, 2008
ClinicalTrials.gov Identifier: NCT00745628     History of Changes
Health Authority: China: Ministry of Health

Keywords provided by Ministry of Science and Technology of the People´s Republic of China:
coronary heart disease
secondary prevention

Study placed in the following topic categories:
Arterial Occlusive Diseases
Coronary Disease
Heart Diseases
Myocardial Ischemia
Vascular Diseases
Neoplasm Metastasis
Arteriosclerosis
Ischemia
Coronary Artery Disease

Additional relevant MeSH terms:
Arterial Occlusive Diseases
Coronary Disease
Heart Diseases
Myocardial Ischemia
Vascular Diseases
Cardiovascular Diseases
Arteriosclerosis
Coronary Artery Disease

ClinicalTrials.gov processed this record on September 10, 2009